Stereotactical Radiotherapy in the Hepatocellular Carcinoma (HCC). A single-center Phase II Study

被引：0
|
作者：
Brunner, T. B. [1 ]
Kirste, S. [1 ]
Schultheiss, M. [2 ]
Euringer, W. [3 ]
Neeff, H. [4 ]
Schulenburg, M. [5 ]
Thimme, R. [2 ]
Grosu, A. L. [1 ]
机构：
[1] Uniklin Freiburg, Klin Strahlenheilkunde, Freiburg, Germany
[2] Uniklin Freiburg, Freiburg, Germany
[3] Uniklin Freiburg, Radiol Klin, Freiburg, Germany
[4] Uniklin Freiburg, Klin Allgemein & Viszeralchirurg, Freiburg, Germany
[5] Uniklin Freiburg, Klin Nukl Med, Freiburg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [21] A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
    Herr, Daniel J.
    Wang, Chang
    Mendiratta-Lala, Mishal
    Matuszak, Martha
    Mayo, Charles S.
    Cao, Yue
    Parikh, Neehar D.
    Ten Haken, Randy
    Owen, Dawn
    Evans, Joseph R.
    Stanescu, Teodor
    Yan, Michael
    Dawson, Laura A.
    Schipper, Matthew
    Lawrence, Theodore S.
    Cuneo, Kyle C.
    CLINICAL CANCER RESEARCH, 2023, 29 (19) : 3852 - 3858
  • [22] Stereotactic body radiotherapy treatment for hepatocellular carcinoma: A phase II study
    Durand-Labrunie, J.
    Jarraya, H.
    Boleslawski, E.
    Cattan, S.
    Lacornerie, T.
    Peiffert, D.
    Mirabel, X.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S57 - S57
  • [23] PHASE II STUDY OF CONCOMITANT THALIDOMIDE DURING RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA
    Ch'ang, Hui-Ju
    Hsu, Chiun
    Chen, Chien-Hung
    Chang, Ya-Hui
    Chang, Jeffrey S.
    Chen, Li-Tzong
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 817 - 825
  • [24] Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma
    Kawashima, M
    Furuse, J
    Nishio, T
    Konishi, M
    Ishii, H
    Kinoshita, T
    Nagase, M
    Nihei, KI
    Ogino, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1839 - 1846
  • [25] Liver Transplantation in Patients with Hepatocellular Carcinoma (HCC): A Single Center Experience
    Azzam, Ayman
    Hegab, Bassem
    Khalaf, Hatem
    Al Bahili, Hamad
    Mohammed, Hazem
    Kamel, Yasser
    Khail, Faisal Abal
    Al-Hamoudi, Waleed
    Al Sofayan, Mohammad
    Al Sebayel, Mohammed
    LIVER TRANSPLANTATION, 2011, 17 (06) : S274 - S275
  • [26] Irreversible Electroporation for Hepatocellular Carcinoma Abutting the Diaphragm: A Prospective Single-center Study
    Ma, Yangyang
    Chen, Zhixian
    Liang, Bing
    Li, Rongrong
    Li, Jianyu
    Li, Zhonghai
    Lin, Mao
    Niu, Lizhi
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (02) : 190 - 196
  • [27] Treatment outcomes with sorafenib in advanced hepatocellular carcinoma: A single-center retrospective study
    Prejac, J.
    Tomek, D.
    Kekez, D.
    Majerovic, M.
    Plestina, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S194 - S194
  • [28] Phase II study of pembrolizumab (pembro) and bavituximab (bavi) in advanced hepatocellular carcinoma (HCC)
    Hsiehchen, D.
    Kainthla, R.
    Zhu, H.
    Jones, A.
    Beg, M. S.
    ANNALS OF ONCOLOGY, 2021, 32 : S822 - S823
  • [29] A phase II study of arsenic trioxide (ATO) in patients with advanced hepatocellular carcinoma (HCC)
    Rodgers, H. A.
    Katta, S. F.
    Malani, A. K.
    Willis, M.
    Markowitz, A. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] A phase II study of ABT-869 in hepatocellular carcinoma (HCC): Interim analysis
    Toh, H.
    Chen, P.
    Carr, B. I.
    Knox, J. J.
    Gill, S.
    Steinberg, J.
    Carlson, D. M.
    Qian, J.
    Qin, Q.
    Yong, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345